Delivery Order SPE2DR25D3004-SPE2DR26FXTG3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical product. This competitively awarded, non-set-aside contract carries a ceiling value of $15,327.29 with firm fixed pricing and is scheduled for completion by January 6, 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,770.89 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $4,098.96 to AmerisourceBergen Drug Corp's Corporate Office Division on May 20, 2024. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide...
- AmerisourceBergen Drug Corp was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) on December 11, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mL with a ceiling value of $1,193.97. The contract, which is a child order under a larger vehicle, represents a non-set-aside competitive award with an ultimate completion date of December 12, 2025. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,541.48 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,794.38 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has an ultimate completion date of August 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies through an existing Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical. This IDC...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has a completion date of February 8, 2024 and a potential value of $2,770.74. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Humira Pen 40 mg/0.8 mL pharmaceuticals. The $1,385.37 contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, serving as the primary vehicle to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,328.55 and is scheduled for completion by December 31, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This competitively awarded, non-set-aside contract has a ceiling value of $67,903.44 with firm fixed pricing and is scheduled for completion by December 16, 2025. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, will serve...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXTG3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls with a ceiling value of $5,173.87. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of January 9, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and vaccines to support military healthcare programs worldwide. AmerisourceBergen is a subsidiary of Cencora, Inc., which holds the parent IDC relationship with DLA valued at up to $999,999,999.00 through December 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 1/7/26 |